These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
Preliminary Proxy Statement
|
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
x
|
Definitive Proxy Statement
|
|
|
o
|
Definitive Additional Materials
|
|
|
o
|
Soliciting Material Under Rule 14a-12
|
|
x
|
No fee required.
|
||
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
||
|
1)
|
Title of each class of securities to which transaction applies:
|
||
|
2)
|
Aggregate number of securities to which transaction applies:
|
||
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
||
|
4)
|
Proposed maximum aggregate value of transaction:
|
||
|
5)
|
Total fee paid:
|
||
|
o
|
Fee paid previously with preliminary materials.
|
||
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing:
|
||
|
1)
|
Amount previously paid:
|
||
|
2)
|
Form, Schedule or Registration Statement No:
|
||
|
3)
|
Filing Party:
|
||
|
4)
|
Date Filed:
|
||
|
|
1.
|
Elect the three directors named in the attached Proxy Statement, each for a term of three years;
|
|
|
2.
|
Ratify the appointment of PricewaterhouseCoopers LLP as Ormat Technologies, Inc.’s independent registered public accounting firm for the year ending December 31, 2015; and
|
|
|
3.
|
Transact any other business that may properly come before the meeting or any postponements or adjournments of the meeting.
|
|
|
·
|
This Proxy Statement, the proxy card form, the Notice of Internet Availability of Proxy Materials and our Annual Report on Form 10-K are available at
http://materials.proxyvote.com/686688
by clicking on the proxy link.
|
|
|
·
|
You will need your assigned control number to vote your shares. Your control number can be found on your proxy card or voting instruction form.
|
|
|
·
|
The time and location of the Annual Meeting of Stockholders are noted above.
|
|
By order of the Board of Directors,
/s/ Isaac Angel
Isaac Angel
Chief Executive Officer
|
|
1
|
|
|
Questions and Answers about the 2015 Annual Meeting of Stockholders
|
2
|
|
6
|
|
|
Our Current Nominees
|
6
|
|
Our Continuing Directors
|
8
|
|
10
|
|
|
Board Leadership Structure
|
10
|
|
Board Committees
|
10
|
|
Majority Voting for Directors
|
13
|
|
Compensation Committee Interlocks and Insider Participation
|
13
|
|
Code of Business Conduct and Ethics
|
14
|
|
Corporate Governance Guidelines
|
14
|
|
Executive Sessions
|
14
|
|
Stockholder Communications with the Board of Directors
|
14
|
|
Board's Role in Risk Oversight
|
14
|
|
15
|
|
|
17
|
|
|
19
|
|
|
23
|
|
|
26
|
|
|
27
|
|
|
Summary Compensation Table
|
27
|
|
Grants of Plan-Based Awards
|
30
|
|
Employment Agreements
|
31
|
|
Outstanding Equity Awards at Fiscal Year-End
|
32
|
|
Option Exercises
|
33
|
|
Potential Payments upon Termination or Change in Control
|
34
|
|
Estimated Payments and Benefits upon Termination
|
36
|
|
36
|
|
38
|
|
|
41
|
|
|
41
|
|
|
43
|
|
|
Appointment of Registered Public Accounting Firm
|
43
|
|
Audit and Non-Audit Fees
|
43
|
|
Audit Committee Pre-Approval Procedures for Independent Registered Public Accounting Firm
|
43 |
|
45
|
|
|
45
|
|
|
Householding of Proxies
|
45
|
|
Additional Filings
|
45
|
|
Proxy Solicitation
|
45
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
46
|
|
Stockholder Proposals for 2016 Annual Meeting of Stockholders
|
46
|
|
|
·
|
vote by internet or by telephone and how you can receive a paper or email copy of a proxy card if you are a record holder of shares; or
|
|
|
·
|
give voting instructions to your bank or brokerage firm if your shares are held in street name.
|
|
|
● by signing and delivering another proxy with a later date;
|
|
|
● by giving written notice of such revocation to the Corporate Secretary of Ormat prior to or at the meeting; or
|
|
|
● by voting in person at the meeting.
|
|
|
●
|
The election of the three nominees named in this proxy statement to the Board of Directors; and
|
|
|
● The ratification of PricewaterhouseCoopers LLP as Ormat’s independent registered public accounting firm for the year ending December 31, 2015.
|
|
|
Class I Directors (term expiring upon the annual stockholders meeting in 2017)
|
|
|
Yoram Bronicki
|
|
|
David Granot*
|
|
|
Robert E. Joyal*
|
|
|
Class II Directors (term expiring at the meeting)
|
|
|
Yehudit Bronicki
|
|
|
Robert F. Clarke*
|
|
|
Class III Directors (term expiring upon the annual stockholders meeting in 2016)
|
|
|
Gillon Beck*
|
|
|
Dan Falk*
|
|
* Designated as independent director.
|
|
|
·
|
Yehudit “Dita” Bronicki
.
Yehudit Bronicki served as our Chief Executive Officer from July 1, 2004 until June 30, 2014. During this time period, she was also a member of our Board of Directors, a position that she continues to hold since 1994, and is a member of the Board of Directors of some of our material subsidiaries. From 1992 to June 2005 and from March 2012 to August 2012, Mrs. Bronicki was a director of Bet Shemesh Engines, a manufacturer of jet engines. In addition, since 2000, Mrs. Bronicki has been a member of the Board of Directors of Orbotech Ltd., a NASDAQ publicly traded company. From 1994 to 2001, Mrs. Bronicki was on the Advisory Board of the Bank of Israel. Mrs. Bronicki has worked in the power industry since 1965. She is the mother of Yoram Bronicki, the Chairman of our Board of Directors. Mrs. Bronicki obtained a Bachelor of Arts in Social Sciences from Hebrew University in 1965. In 2007, she received a PhD. Honoris Causa from the Technion – Israel Institute of Technology. Mrs. Bronicki is 73 years old.
|
|
|
·
|
Robert F. Clarke
.
Robert F. Clarke has been a member of our Board of Directors since February 27, 2007. Mr. Clarke was Chairman (since September 1998) and President and Chief Executive Officer (since January 1991) of Hawaiian Electric Industries, Inc. (HEI), from which he retired effective May 2006. Since June 1, 2006, Mr. Clarke has been Executive in Residence at the Shidler College of Business at the University of Hawaii. In addition, Mr. Clarke serves as an advisory director to Oceanic Cable Hawaii, and as a member of the advisory boards of the Shidler College of Business at the University of Hawaii, Sennet Capital, and Aina Koa Pono, a Hawaii based privately held company exploring renewable energy projects in converting biomass into fuels. Mr. Clarke joined HEI in February 1987 as Vice President of Strategic Planning and was in charge of implementing the Company’s diversification strategy. Mr. Clarke was named HEI Group Vice President — Diversified Companies in May 1988. He was made a director of HEI in 1989.
Prior to joining HEI, Mr. Clarke served as Senior Vice President and Chief Financial Officer of Alexander & Baldwin and as Controller of Dillingham Corporation. Prior to that, he worked for the Ford Motor Company and for the Singer Company. He received his Bachelor’s degree in economics in 1965 and his Master’s degree in finance in 1966 from the University of California at Berkeley. Honors include Phi Beta Kappa in 1965. Mr. Clarke is 72 years old.
The Board, following recommendation of our Nominating and Corporate Governance Committee, has concluded that Mr. Clarke should serve as director of the Company primarily because of his 28 years of experience in the power/energy industry, his extensive management experience, and his overall business and financial knowledge.
|
|
|
·
|
Ami Boehm
. Ami Boehm has been a member of our Board of Directors since May 22, 2012. Since 2004, Mr. Boehm has been a Partner at FIMI Opportunity Funds, as well as Managing Partner and CEO of FITE GP (2004). In addition, Mr. Boehm currently serves as a member of the Board of Directors of Gilat Satellite Networks Ltd. and Magal Security Systems Ltd., both NASDAQ publicly traded companies, and of Ham-Let (Israel Canada) Ltd., a non-U.S. public company. He also serves as a member of the Board of Directors of Dimar Ltd. and Novolog (Pharm Up 1996) Ltd., two private companies. During the past five years, Mr. Boehm formerly served as a member of the Board of Directors of the following non-U.S. public companies: Global Wire Ltd., Telkoor Telecom Ltd., Scope Metal Trading, Ltd. and Inter Industries Ltd. From 1999 to 2004, Mr. Boehm served as Head of Research at Discount Capital Markets, the investment arm of Israel Discount Bank, and from 1998 to 1999, he worked in the Office of the Attorney General in the Israeli Ministry of Justice. Mr. Boehm received a Bachelor of Law degree in 1997 from Tel Aviv University, a Bachelor of Arts degree in Economics in 1998 from Tel Aviv University, and a Masters of Business Administration in Finance in 2004 jointly from Northwestern University's Kellogg School of Business and Tel Aviv University. Mr. Boehm is 43 years old.
The Board, following recommendation of our Nominating and Corporate Governance Committee, has concluded that Mr. Boehm should serve as a director of the Company primarily because of his extensive experience in finance and strategic initiatives, and his overall management and business knowledge.
|
|
|
·
|
making recommendations to the Board as to changes in Ormat’s general compensation philosophy;
|
|
|
·
|
overseeing the development and implementation of compensation programs;
|
|
|
·
|
reviewing and approving corporate goals and objectives relevant to the compensation of the CEO, and evaluating the performance of the CEO in light of those goals and objectives; and
|
|
|
·
|
reviewing and approving the annual compensation of the CEO and Ormat’s five other most highly compensated executive officers who receive total compensation in excess of $1 million per year.
|
|
Dan Falk, Chair
Robert F. Clarke
David Granot
Robert E. Joyal
|
|
Name
|
Age
|
Position
|
||
|
Isaac Angel
|
58
|
Chief Executive Officer
|
||
|
Doron Blachar
|
47
|
Chief Financial Officer
*
|
||
|
Zvi Krieger
|
59
|
Executive Vice President—Electricity Segment
*
|
||
|
Bob Sullivan
|
52
|
Executive Vice President - Business Development Sales and Marketing
|
||
|
Shlomi Argas
|
50
|
Executive Vice President - Projects
*
|
||
|
Shimon Hatzir
|
53
|
Executive Vice President—Engineering
*
|
||
|
Erez Klein
|
49
|
Executive Vice President - Production
*
|
||
|
Nir Wolf
|
49
|
Executive Vice President – Market Development
*
|
||
|
Etty Rosner
|
59
|
Corporate Secretary; Senior Vice President—Contract Management
*
|
|
|
● each person, or group of affiliated persons, known to us to own beneficially 5% or more of our outstanding Common Stock;
|
|
|
● each of our directors;
|
|
|
● each of our Named Executive Officers (as defined under "Summary Compensation Table" below); and
|
|
|
● all of our directors and executive officers as a group.
|
|
Shares of
Common Stock
Beneficially Owned
|
||||||||
|
Number
|
Percent
|
|||||||
|
Principal Stockholder:
|
||||||||
|
FIMI ENRG, L.P. and FIMI ENRG, Limited Partnership
|
11,607,361 | (1) | 23.87 | % | ||||
|
Bronicki Investments Ltd.
|
11,607,361 | (1) | 23.87 | % | ||||
|
Migdal Insurance & Financial Holdings Ltd.
|
4,577,323 | (2) | 9.41 | % | ||||
|
Clal Insurance Enterprises Holdings Ltd.
|
3,753,966 | (3) | 7.72 | % | ||||
|
Psagot Investment House Ltd.
|
2,563,935 | (4) | 5.27 | % | ||||
|
Directors and Named Executive Officers
|
||||||||
|
Yoram Bronicki
†
|
4,293,243 | (5) | 8.83 | % | ||||
|
Gillon Beck
††
|
7,336,618 | (6),(7) | 15.08 | % | ||||
|
Yehudit Bronicki
†
|
4,293,243 | (5) | 8.83 | % | ||||
|
Dan Falk
††
|
22,500 | (8) | — | |||||
|
Ami Boehm
††
|
7,336,618 | (6),(9) | 15.08 | % | ||||
|
Robert F. Clarke
††
|
39,500 | (10) | — | |||||
|
Robert E. Joyal
††
|
22,500 | (11) | — | |||||
|
David Granot
††
|
18,750 | (12) | — | |||||
|
Isaac Angel
|
— | — | ||||||
|
Doron Blachar
†
|
66,250 | (13) | — | |||||
|
Zvi Krieger
|
98,000 | (14) | — | |||||
|
Shimon Hatzir
|
99,072 | (15) | — | |||||
|
Nir Wolf
|
73,000 | (16) | — | |||||
|
Directors and Named Executive Officers as a group
|
12,089,934 | (17) | 24.90 | % | ||||
|
|
† c/o Ormat Systems Ltd., Industrial Area, P.O. Box 68 Yavne 81100, Israel
|
|
|
†† c/o Ormat Technologies, Inc., 6225 Neil Road, Reno, Nevada 89511
|
|
|
* Represents beneficial ownership of less than 1% of the outstanding shares of Common Stock.
|
|
(1)
|
The information provided for FIMI ENRG, L.P. ("FIMI ENRG 1") and FIMI ENRG, Limited Partnership ("FIMI ENRG 2", and together with FIMI ENRG 1, "FIMI") and Bronicki Investments is based on their respective Schedule 13Ds filed with the SEC on February 17, 2015. As reported therein, FIMI is the beneficial owner of 7,314,118 shares, representing a beneficial ownership of 15.06% of our shares, and Bronicki Investments is the beneficial owner of 4,293,243 shares, representing a beneficial ownership of 8.18% of our shares. FIMI and Bronicki Investments are party to (i) a shareholder rights agreement, dated March 16, 2012, which was amended and restated on November 10, 2014, and (ii) a share purchase agreement, dated March 16, 2012. By virtue of the shareholder rights agreement, each of FIMI and Bronicki may be deemed to beneficially own, and have shared voting power over, the shares of our Common Stock beneficially owned by the other party to the shareholder rights agreement, such that, collectively, they may be deemed to beneficially own 11,607,361 shares, representing a beneficial ownership of 23.92% of our shares. Each of FIMI and Bronicki Investments disclaims beneficial ownership of all shares of our Common Stock beneficially owned by the other party to the shareholder rights agreement. FIMI's address is 98 Yigal Alon Street, Tel- Aviv, Israel 67891. Bronicki Investments' address is 5H’ Brosh 5 Street, Yavne, Israel 81510. See also footnotes 3 and 4 below.
|
|
(2)
|
The information provided for
Migdal Insurance & Financial Holdings Ltd
. ("Migdal) is based on Migdal's Schedule 13G filed with the SEC on February 25, 2015. Migdal reported shared voting and dispositive power with regard to all of the
4,577,323
shares beneficially held by Migdal and stated that of the 4,577,323 shares reported
(i)
4,298,785
shares are held for members of the public through, among others, provident funds, mutual funds, pension funds and insurance policies, which are managed by subsidiaries of Migdal, according to the following segmentation:
2,435,452
shares are held by profit participating life assurance accounts,
1,678,295
shares are held by provident funds and companies that manage provident funds and
185,038
shares are held by companies for the management of funds for joint investments in trusteeship, each of which subsidiaries operates under independent management and makes independent voting and investment decisions, and (ii)
278,538
are beneficially held for their own account (Nostro account).
Migdal disclaims beneficial ownership of 4,298,785 of these shares. Migdal's address is
4 Efal Street; P.O. Box 3063; Petach Tikva 49512, Israel
.
|
|
(3)
|
The information provided for Clal Insurance Enterprises Holdings Ltd. ("Clal") is based on Clal's Schedule 13G/A filed with the SEC on February 17, 2015. Clal reported shared voting and dispositive power with regard to all of the 3,753,966 shares beneficially held by Clal and stated that of the 3,753,966 shares reported (i) 3,639,098 are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by subsidiaries of Clal, which subsidiaries operate under independent management and make independent voting and investment decisions and (ii) 114,868 shares are beneficially held for its own account. Clal disclaims that it is the beneficial owner of more than 114,868 shares. Clal's address is 48 Menachem Begin Road, Tel Aviv 66180, Israel.
|
|
(4)
|
The information provided for Psagot Investment House Ltd. ("Psagot") is based on Psagot's Schedule 13G filed with the SEC on February 23, 2015. Psagot reported shared voting and dispositive power with regard to 2,137,144 shares beneficially held by Psagot and stated that of the 2,563,935 shares reported (i)
426,791 shares are beneficially owned by portfolio accounts managed by Psagot Securities Ltd.
, (ii)
769,320 shares are beneficially owned by Psagot Exchange Traded Notes Ltd., (iii) 195,817 shares are beneficially owned by mutual funds managed by Psagot Mutual Funds Ltd. (of this amount, 10,938 shares may also be considered beneficially owned by Psagot Securities Ltd., but are not included in the shares beneficially owned by Psagot Securities Ltd., as indicated above)
and (iv)
1,172,007 shares are beneficially owned by provident funds and pension funds managed by Psagot Provident Funds and Pension Ltd.
Psagot disclaims beneficial ownership of all of these shares. Psagot's address is Psagot Investment House Ltd. - 14 Ahad Ha’am Street, Tel Aviv 6514211, Israel.
|
|
(5)
|
The information provided herein is based, in part, on the Schedule 13D filed by Bronicki Investments with the SEC on February 17, 2015. Yehudit Bronicki is a director in Bronicki Investments Ltd. and, together with her husband Lucien Bronicki, has voting control of the shares of our Common Stock held by Bronicki Investments, and beneficially owns 20% of Bronicki Investments. Accordingly,
she may be deemed by virtue of her relationship with Bronicki Investments to beneficially own and have shared power of disposition and voting over the shares of Common Stock beneficially owned by Bronicki Investments.
Ms. Bronicki disclaims beneficial ownership of all shares of Common Stock held by Bronicki Investments, except to the extent of her 20% ownership of Bronicki Investments. Yoram Bronicki beneficially owns 20% of Bronicki Investments, and
accordingly he may be deemed by virtue of his relationship with Bronicki Investments to beneficially own the shares of Common Stock beneficially owned by Bronicki Investments.
Mr. Bronicki does not have voting control or dispositive control over the shares of Common Stock held by Bronicki Investments. Mr. Bronicki disclaims beneficial ownership of the reported securities except to the extent of his 20% ownership of Bronicki Investments. See also footnote 1 above.
|
|
(6)
|
The information provided herein is based, in part, on the Schedule 13D filed by FIMI with the SEC on February 17, 2015. Includes 7,314,118 shares beneficially owned by FIMI. Each of Gillon Beck and Ami Boehm is a partner of FIMI and has voting control of the shares held by FIMI. Accordingly, they may be deemed to share beneficial ownership of the shares held by FIMI. Each of Gillon Beck and Ami Boehm disclaim beneficial ownership of all such shares.
See also footnote 1 above.
|
|
(7)
|
Includes 22,500 shares of Common Stock issuable to Mr. Beck upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Beck have exercise prices that range between $18.56 and $26.70 per share of Common Stock and expire at different periods between August 1, 2019 and November 5, 2020.
See also footnote 1 above.
|
|
(8)
|
Includes 22,500 shares of Common Stock issuable to Mr. Falk upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Falk have exercise prices that range between $18.56 and $38.50 per share of Common Stock and expire at different periods between November 5, 2016 and November 5, 2020.
|
|
(9)
|
Includes 22,500 shares of Common Stock issuable to Mr. Boehm upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Boehm have exercise prices that range between $18.56 and $26.70 per share of Common Stock and expire at different periods between August 1, 2019 and November 5, 2020.
See also footnote 1 above.
|
|
(10)
|
Includes (a) 2,000 shares of Common Stock purchased at market and (b) 37,500 shares of Common Stock issuable to Mr. Clarke upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Clarke have exercise prices that range between $18.56 and $38.50 per share of Common Stock and expire at different periods between November 5, 2015 and November 5, 2020.
|
|
(11)
|
Includes 22,500 shares of Common Stock issuable to Mr. Joyal upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Joyal have exercise prices that range between $18.56 and $26.70 per share of Common Stock and expire at different periods between August 1, 2019 and November 5, 2020.
|
|
(12)
|
Includes 18,750 shares of Common Stock issuable to Mr. Granot upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Granot have exercise prices that range between $18.56 and $26.70 per share of Common Stock and expire at different periods between August 1, 2019 and November 5, 2020.
|
|
(13)
|
Includes 66,250 shares of Common Stock issuable to Mr. Blachar upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Blachar have an exercise price that range between $20.54 to $24.57 per share of Common Stock and expire between February 9, 2019 to April 2, 2019.
|
|
(14)
|
Includes 98,000 shares of Common Stock issuable to Mr. Krieger upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Krieger have exercise prices that range between $20.13 and $45.78 per share of Common Stock and expire at different periods between April 8, 2015 and June 4, 2019.
|
|
(15)
|
Includes 99,072 shares of Common Stock issuable to Mr. Hatzir upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Hatzir have exercise prices that range between $20.13 and $45.78 per share of Common Stock and expire at different periods between April 8, 2015 and June 4, 2019.
|
|
(16)
|
Includes 73,000 shares of Common Stock issuable to Mr. Wolf upon the exercise of options that are exercisable within 60 days of March 5, 2015. The options granted to Mr. Wolf have exercise prices that range between $20.13 and $45.78 per share of Common Stock and expire at different periods between April 8, 2015 and June 4, 2019.
|
|
(17)
|
This number includes (a)
11,607,362
shares of Common Stock and (b) options
(including SARs)
to purchase
482,572
shares of Common Stock of the Company exercisable within 60 days of March 5 , 2015, held directly (or deemed to be beneficially owned) by all of our directors and executive officers as a group. These options have exercise prices that range between $18.56 and $45.78 per share of Common Stock and expire at different periods between April 8, 2015 and November 5, 2021.
|
|
COM
PE
NSATION DISCUSSION AND ANALYSIS
|
|
|
1.
|
Annual salary, which is paid bi-monthly, is intended to provide an annual income at a level consistent with individual contributions.
|
|
|
2.
|
Annual bonuses, which are paid semi-annually for our executives, are intended to link our executive officers’ compensation to the Company’s overall performance, as well as, in most cases, their individual achievements.
|
|
|
3.
|
Equity awards are designed to promote long-term leadership and align the interests of our executives with those of our stockholders, while the vesting schedule assists us in retaining our executives in our employ. Equity awards typically begin to vest following two years from the date of grant, with 25% vesting on each of the second and third anniversaries of the date of grant and the remaining 50% on the fourth anniversary of the date of grant. All employees and consultants of the Company are eligible to receive equity awards pursuant to the Company's incentive compensation plan. The term of our equity awards typically ranges from six to ten years from the date of grant; as to our current executives, with the exception of two of our current NEOs, there is no provision that provides for accelerated vesting upon a change in control; and there is no holding period for vested options.
|
|
Each element is determined individually, based on the relevant criteria described in this discussion.
|
|
Yehudit Bronicki, Chair
Dan Falk
Ami Boehm
David Granot
|
|
Name and Principal Position
|
Year
|
Salary($)
|
Bonus($)
|
Option Awards ($) (1)
|
All Other Compensation ($)
|
Total ($)
|
|||||||||||||||||
|
Isaac Angel, Chief Executive Officer (2)
|
2014
|
368,577 | 318,750 | 3,785,820 | 80,901 | (3) | 4,554,048 | ||||||||||||||||
|
Doron Blachar, Chief Financial Officer
|
2014
|
358,118 | 62,566 | 187,871 | 96,540 | (4) | 705,095 | ||||||||||||||||
|
2013
|
263,470 | — | 564,000 | 63,756 | 891,226 | ||||||||||||||||||
|
Zvi Krieger, Executive Vice President of the Electricity Segment
|
2014
|
226,465 | 78,208 |
None
|
74,789 | (5) | 379,462 | ||||||||||||||||
|
2013
|
211,640 | — | 337,500 | 72,924 | 622,064 | ||||||||||||||||||
|
2012
|
198,015 | — | 175,560 | 63,829 | 437,404 | ||||||||||||||||||
|
Shimon Hatzir, Executive Vice President of Engineering
|
2014
|
217,337 | 42,659 |
None
|
65,238 | (6) | 325,234 | ||||||||||||||||
|
2013
|
211,012 | — | 337,500 | 61,074 | 609,586 | ||||||||||||||||||
|
2012
|
198,114 | — | 175,560 | 69,052 | 442,726 | ||||||||||||||||||
|
Nir Wolf, Executive Vice President for Market Development
|
2014
|
219,459 | 78,208 |
None
|
70,405 | (7) | 368,072 | ||||||||||||||||
|
2013
|
214,257 | — | 337,500 | 62,849 | 614,606 | ||||||||||||||||||
|
2012
|
201,172 | — | 175,560 | 57,348 | 434,080 | ||||||||||||||||||
|
Yehudit Bronicki, Director (
Former Chief Executive Officer
) (8)
|
2014
|
75,000 | 198,750 | (9) | 55,714 | 72,356 | (10) | 401,820 | |||||||||||||||
|
2013
|
150,000 | 294,285 | (9) |
None
|
63,356 | 507,641 | |||||||||||||||||
|
2012
|
150,000 | — |
None
|
62,025 | 212,025 | ||||||||||||||||||
|
Yoram Bronicki, Chairman of the Board of Directors (
Former President and Chief Operating Officer
) (11)
|
2014
|
168,000 | 331,250 | (12) |
None
|
76,627 | (13) | 575,877 | |||||||||||||||
|
2013
|
168,000 | 294,285 | (12) |
None
|
66,103 | 528,388 | |||||||||||||||||
|
2012
|
168,000 | — |
None
|
78,472 | 246,472 | ||||||||||||||||||
|
(1)
|
Represents the grant date fair value of all option awards in accordance with accounting guidance for stock compensation. The awards were SARs. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
The fair value of each grant of stock-based awards on the date of grant is estimated using the Black-Scholes valuation model and the assumptions noted in the following table.
|
|
Year Ended December 31,
|
||||||||||||
|
2014
|
2013
|
2012
|
||||||||||
|
Risk-free interest rates
|
1.7 | % | 0.8 | % | 1.0 | % | ||||||
|
Expected lives (in years)
|
5.1 | 4.6 | 5.0 | |||||||||
|
Dividend yield
|
0.9 | % | 0.71 | % | 0.81 | % | ||||||
|
Expected volatility
|
35.1 | % | 37.8 | % | 47.2 | % | ||||||
|
Forfeiture rate
|
0.0 | % | 5.6 | % | 6.4 | % | ||||||
|
(2)
|
Isaac Angel commenced serving as an officer of the Company on April 1, 2014, and assumed the position of Chief Executive Officer as of July 1, 2014.
|
|
(3)
|
Includes payments of car-related expenses in the amount of $16,442; Israel National Insurance in the amount of $6,815; U.S. Social Security in the amount of $2,648; health insurance in the amount of $109; Defined Contribution Plan in the amount of $48,431; Education Fund in the amount of $2,931; and perquisites amounting to $3,525.
|
|
(4)
|
Includes payments of car-related expenses in the amount of $22,826; Israel National Insurance in the amount of $9,166; health insurance in the amount of $51; convalescence pay in the amount of $3,215; Defined Contribution Plan in the amount of $52,462; Education Fund in the amount of $3,944; and perquisites amounting to $4,876.
|
|
(5)
|
Includes payments of car-related expenses in the amount of $13,957; Israel National Insurance in the amount of $9,166; health insurance in the amount of $51; convalescence pay in the amount of $1,837; Defined Contribution Plan in the amount of $32,749; Education Fund in the amount of $3,944; vacation redemption of $11,805; and perquisites amounting to $1,280.
|
|
(6)
|
Includes payments of car-related expenses in the amount of $13,957; Israel National Insurance in the amount of $9,166; convalescence pay in the amount of $1,837; Defined Contribution Plan in the amount of $31,479; Education Fund in the amount of $3,944; and perquisites amounting to $4,855.
|
|
(7)
|
Includes payments of car-related expenses in the amount of $16,065; Israel National Insurance in the amount of $9,166; health insurance in the amount of $51; convalescence pay in the amount of $1,837; Defined Contribution Plan in the amount of $35,662; Education Fund in the amount of $3,944; and perquisites amounting to $3,680.
|
|
(8)
|
Yehudit Bronicki served as our Chief Executive Officer from July 1, 2004 until June 30, 2014.
During this time period, she was also a member of our Board of Directors, a position that she continues to hold.
|
|
(9)
|
Represents the annual bonus paid to Mrs. Bronicki from the Company during the period that she served as our Chief Executive Officer, based on formulas that were set forth in her employment agreement.
|
|
(10)
|
Includes payments of car-related expenses in the amount of $14,275; directors fees in the amount of $32,000; Israel National Insurance in the amount of $1,275; U.S. Social Security in the amount of $2,295; health insurance in the amount of $232; convalescence pay in the amount of $1,837; Defined Contribution Plan in the amount of $17,893; Education Fund in the amount of $1,426; and perquisites amounting to $1,123.
|
|
(11)
|
Yoram Bronicki served as our President and Chief Operating Officer from July 1, 2004 until June 30, 2014, and as a member of our Board of Directors since November 12, 2004.
Mr. Bronicki assumed the position of Chairman of our Board of Directors as of June 30, 2014.
|
|
(12)
|
Represents the annual bonus paid to Mr. Bronicki from the Company, based on formulas that are set forth in his employment agreement. Pursuant to Mr. Bronicki's employment agreement, as of June 30, 2014 his annual bonus is equal to 0.5% of the Company’s annual consolidated profits (after tax) above $2,000,000 up to a maximum of six times his annual base salary.
|
|
(13)
|
Includes payments of car-related expenses in the amount of $14,275; Israel National Insurance in the amount of $8,414; U.S. Social Security in the amount of $10,550; health insurance in the amount of $14,795; convalescence pay in the amount of $1,837; 401(k) Plan matching contribution in the amount of $3,500; Defined Contribution Plan in the amount of $18,111; Education Fund in the amount of $2,366; and perquisites amounting to $2,779.
|
|
Grants of Plan-Based Awards
|
|
Name
|
Grant Date
|
All Other Option Awards: Number of Securities Underlying Options
|
Exercise Price of
Option
Awards ($/Sh)
|
Grant Date Fair Value of
Option Awards ($)
(1)
|
||||||||||
|
Isaac Angel
|
April 1, 2014
|
100,000 | (2) | 29.52 | 1,287,637 | (3) | ||||||||
|
Isaac Angel
|
April 1, 2014
|
300,000 | (4) | 29.52 | 2,498,183 | (5) | ||||||||
|
Doron Blachar
|
February 10, 2014
|
32,500 | (6) | 24.57 | 187,871 | (8) | ||||||||
|
Zvi Krieger
|
None
|
None
|
N/A | N/A | ||||||||||
|
Shimon Hatzir
|
None
|
None
|
N/A | N/A | ||||||||||
|
Nir Wolf
|
None
|
None
|
N/A | N/A | ||||||||||
|
Yehudit Bronicki
|
November 5, 2014
|
7,500 | (7) | 28.23 | 55,714 | |||||||||
|
Yoram Bronicki
|
None
|
None
|
N/A | N/A | ||||||||||
|
|
(1)
|
These amounts are the grant date fair value of each award, computed in accordance with accounting guidance for stock compensation using the Black-Scholes valuation model.
|
|
|
(2)
|
These grants were stock options, which will become fully vested seven years following the date of the grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control.
|
|
|
(3)
|
The fair value of the options granted to Mr. Angel and recorded as compensation expenses in our consolidated financial statements for the year ended December 31, 2014, based on the fair value of this options grant, in accordance with accounting guidance for equity-based compensation, was $137,961. For a discussion of the assumptions used in reaching this valuation, see Note 1 to the Summary Compensation Table above.
|
|
|
(4)
|
These grants were stock options that will vest in four equal installments, commencing March 31, 2016. The options expire six years from the date of grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control.
|
|
|
(5)
|
The fair value of the options granted to Mr. Angel and recorded as compensation expenses in our consolidated financial statements for the year ended December 31, 2014, based on the fair value of this options grant, in accordance with accounting guidance for equity-based compensation, was $601,125. For a discussion of the assumptions used in reaching this valuation, see Note 1 to the Summary Compensation Table above.
|
|
|
(6)
|
These grants were stock options. Options to purchase 16,250 shares of common stock will vest and become exercisable on February 9, 2015, and options to purchase 8,125 shares of common stock will vest and become exercisable on each of February 9, 2016 and 2017. The options expire five years from the date of grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control.
|
|
|
(7)
|
These grants were stock options that will vest on November 5, 2015. The options expire seven years from the date of grant.
|
|
|
(8)
|
The fair value of the options granted in 2014 to Mr. Blachar and recorded as compensation expenses in our consolidated financial statements for the year ended December 31, 2014, based on the fair value of this options grant, in accordance with accounting guidance for equity-based compensation, was $121,986. For a discussion of the assumptions used in reaching this valuation, see Note 1 to the Summary Compensation Table above.
|
|
Employment Agreements
|
|
●
|
Salary: Annual gross salary of NIS 1,620,000 (equal to approximately $407,000 based on the representative exchange rate set by the Bank of Israel on March 5, 2015), which salary is linked to the Israeli consumer price index.
|
|
●
|
Annual Performance Bonus: If the Company's annual consolidated net income ("Annual Profits") is above $20 million, Mr. Angel will be entitled to receive an annual bonus (the "Annual Bonus") equal to (a) 0.75% of Annual Profits of up to $50 million (inclusive), and (b) 1.00% of the portion of the Annual Profits, if any, that is above $50 million; provided that, in any event, the Annual Bonus shall not exceed $750,000.
|
|
●
|
Initial Option Grant: Stock options granted on April 1, 2014
to purchase 100,000 shares of common stock at an exercise price equal to $29.52, the closing price of the common stock on the date of grant. The options were granted under our 2012 Incentive Compensation Plan and vest in one installment on the seventh (7
th
) anniversary of the date of grant. These options expire seven and a half (7.5) years following the grant date.
|
|
|
●
|
Second Option Grant: Stock options granted on April 1, 2014
to purchase 300,000 shares of common stock at an exercise price equal to $29.52, the closing price of the common stock on the date of grant. These options were granted under our 2012 Incentive Compensation Plan and vest in four equal installments, commencing with the second (2
nd
) anniversary of the date of grant. These options expire six (6) years following the grant date.
|
|
●
|
Termination: Each of the Company and Mr. Angel may terminate the employment with the Company, for any reason, by providing six (6) months of prior notice of such termination (the "Notice Period"). Other than in the case of termination of employment with the Company for "cause", Mr. Angel will be entitled to continue to receive his compensation during the Notice Period.
|
|
●
|
Termination in connection with a Change of Control: In the event that Mr. Angel's employment is terminated by the Company without cause, or he resigns for a "good reason", within two (2) months before, or twelve (12) months following, the consummation of a "change of control" (as defined in the Employment Agreement), Mr. Angel is entitled to the following: (i) the Notice Period (and consequently, the period during which compensation is payable to Mr. Angel) will be extended from six (6) months to twelve (12) months; and (ii) all the stock options described above are accelerated and will become fully vested and exercisable.
|
|
Option Awards
|
|||||||||||||
|
Name
|
Number of Securities
Underlying Unexercised Options (#) Exercisable
|
Number of Securities
Underlying Unexercised Options (#) Unexercisable
|
Option
Exercise Price ($)
|
Option Expiration Date
|
|||||||||
|
Isaac Angel
|
None
|
100,000 | (1) | 29.52 |
September 30, 2021
|
||||||||
|
None
|
300,000 | (2) | 29.52 |
March 31, 2020
|
|||||||||
|
Doron Blachar
|
25,000 | 75,000 | (3) | 20.54 |
April 2, 2019
|
||||||||
|
None
|
32,500 | (4) | 24.57 |
February 9, 2019
|
|||||||||
|
Zvi Krieger
|
15,000 |
None
|
34.13 |
April 7, 2016
|
|||||||||
| 24,000 |
None
|
45.78 |
April 8, 2015
|
||||||||||
| 31,200 |
None
|
26.84 |
March 18, 2016
|
||||||||||
| 24,000 |
None
|
29.95 |
April 16, 2017
|
||||||||||
| 12,000 | 12,000 | (5) | 25.65 |
March 31, 2018
|
|||||||||
| 5,500 | 16,500 | (6) | 20.13 |
April 2, 2019
|
|||||||||
|
None
|
50,000 | (7) | 23.34 |
June 4, 2019
|
|||||||||
|
Shimon Hatzir
|
9,000 |
None
|
34.13 |
April 7, 2016
|
|||||||||
| 17,500 |
None
|
45.78 |
April 8, 2015
|
||||||||||
| 22,750 |
None
|
26.84 |
March 18, 2016
|
||||||||||
| 24,000 |
None
|
29.95 |
April 16, 2017
|
||||||||||
| 12,000 | 12,000 | (5) | 25.65 |
March 31, 2018
|
|||||||||
| 2,366 | 16,500 | (6) | 20.13 |
April 2, 2019
|
|||||||||
|
None
|
50,000 | (7) | 23.34 |
June 4, 2019
|
|||||||||
|
Nir Wolf
|
3,500 |
None
|
34.13 |
April 7, 2016
|
|||||||||
| 7,500 |
None
|
45.78 |
April 8, 2015
|
||||||||||
| 9,000 |
None
|
26.84 |
March 18, 2016
|
||||||||||
| 24,000 |
None
|
29.95 |
April 16, 2017
|
||||||||||
| 6,000 | 12,000 | (5) | 25.65 |
March 31, 2018
|
|||||||||
| 5,500 | 16,500 | (6) | 20.13 |
April 2, 2019
|
|||||||||
|
None
|
50,000 | (7) | 23.34 |
June 4, 2019
|
|||||||||
|
Yehudit Bronicki
|
None
|
None
|
N/A |
N/A
|
|||||||||
|
Yoram Bronicki
|
None
|
None
|
N/A |
N/A
|
|||||||||
|
|
(1)
|
These are stock options, which will become fully vested seven years following the date of the grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control, as described above under "Employment Agreements – Isaac Angel".
|
|
|
(2)
|
These are stock options vest in four equal installments, commencing March 31, 2016. The options expire six years from the date of grant. This vesting schedule is subject to acceleration in certain circumstances upon a change of control, as described above under "Employment Agreements – Isaac Angel".
|
|
|
(3)
|
These are stock options which began to vest one year after the April 2013 grant date, with 25% of the stock options vesting on each of the first, second, third, and fourth anniversaries of the grant date. The stock options will become completely exercisable in April 2017.
|
|
|
(4)
|
These are stock options which began to vest one year after the February 2014 grant date, with 50% of the stock options vesting on each of the first and second anniversaries of the grant date. The stock options will become completely exercisable in February 2016.
|
|
|
(5)
|
These are SARs which begin to vest two years after the March 2011 grant date, with 25% of the SARs vesting on each of the second and third anniversaries of the grant date, and the remaining 50% on the fourth anniversary of the grant date. The SARs will become completely exercisable in March 2015. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
|
|
|
(6)
|
These are SARs which begin to vest two years after the April 2012 grant date, with 25% of the SARs vesting on each of the second and third anniversaries of the grant date, and the remaining 50% on the fourth anniversary of the grant date. The SARs will become completely exercisable in April 2016. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
|
|
|
(7)
|
These are SARs which begin to vest two years after the June 2013 grant date, with 25% of the SARs vesting on each of the second and third anniversaries of the grant date, and the remaining 50% on the fourth anniversary of the grant date. The SARs will become completely exercisable in June 2017. Each NEO is entitled to receive shares of Common Stock equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
|
|
Name
|
Termination without Cause ($)
|
Change in Control ($)
|
||||||
|
Isaac Angel
|
274,810 | 549,620 | ||||||
|
Doron Blachar
|
199,808 | 199,808 | ||||||
|
Zvi Krieger
|
337,741 | 337,741 | ||||||
|
Shimon Hatzir
|
526,690 | 526,690 | ||||||
|
Nir Wolf
|
456,358 | 456,358 | ||||||
|
Yehudit Bronicki
|
N/A | N/A | ||||||
|
Yoram Bronicki
|
336,626 | 1,451,414 | ||||||
|
Name
|
Fee Earned or Paid in Cash ($)
|
Options Awards($) (1) (2)
|
Total ($)
|
|||||||||
|
Gillon Beck
|
63,000 | 55,714 | 118,714 | |||||||||
|
Ami Boehm
|
67,500 | 55,714 | 123,214 | |||||||||
|
Dan Falk
|
97,000 | 55,714 | 152,714 | |||||||||
|
Robert F. Clarke
|
80,500 | 55,714 | 136,214 | |||||||||
|
David Granot
|
94,500 | 55,714 | 150,214 | |||||||||
|
Robert E. Joyal
|
59,500 | 55,714 | 115,214 | |||||||||
|
|
(1)
|
Represents the grant date fair value in accordance with accounting guidance for stock compensation. For a discussion of the assumptions used in reaching this valuation, see Note 1 to the Summary Compensation Table above.
|
|
|
(2)
|
At fiscal year end, each non-management director held the following aggregate number of option awards: (i) Mr. Beck held options to purchase 30,000 shares; (ii) Mr. Boehm held options to purchase 30,000 shares; (iii) Mr. Granot held options to purchase 26,250 shares; (iv) Mr. Joyal held options to purchase 30,000 shares; (v) Mr. Falk held options to purchase 30,000 shares; and (vi) Mr. Clarke held options to purchase 45,000 shares.
|
|
The cash compensation of our non-employee directors is as follows:
|
|
|
·
|
Base annual retainer of $40,000 as fees related to their service on our Board of Directors.
|
|
|
·
|
Board meeting fees of $2,500 per day for each in-person meeting attended; $500 per day for each telephonic meeting attended; and $1,000 per day for telephonic participation in an in-person meeting.
|
|
|
·
|
Committee meeting fees of $1,500 per day for each in-person meeting attended and $500 per day for each telephonic meeting attended.
|
|
|
·
|
Any non-employee director who also serves as Chair of the Audit Committee receives an annual retainer of $7,500. Chairs of our other committees do not receive an annual retainer.
|
|
|
·
|
We promptly reimburse all directors for transportation and lodging expenses actually incurred to attend meetings of our Board of Directors or committees.
|
|
|
o
|
voting agreements with the then principal shareholders of Ormat Industries, FIMI and Bronicki, which, following the share exchange, beneficially own approximately 15.06% and 8.84% of our outstanding shares, respectively. Under these voting agreements, FIMI and Bronicki agreed, among other things, to comply in all respects with the Israeli Tax Ruling applicable to the Ormat Industries shareholders.
|
|
|
o
|
voting neutralization agreements with FIMI and Bronicki, whereby FIMI and Bronicki agreed, among other things, to certain restrictions on their shares of our common stock. Among other things, these voting neutralization agreements:
|
|
|
§
|
require these shareholders to vote all voting securities owned by FIMI and Bronicki and their respective affiliates in excess of 16% and 9%, respectively, of the combined voting power of our shares in proportion to votes cast by the other holders of our voting securities at any time any action is to be taken by our stockholders;
|
|
|
§
|
prohibit the acquisition of our voting securities by FIMI and Bronicki and their respective affiliates if after giving effect to any such acquisition FIMI and Bronicki and their respective affiliates would beneficially own voting securities representing in the aggregate more than 20% and 12%, respectively, of the combined voting power of our shares;
|
|
|
§
|
prohibit, prior to January 1, 2017, the sale of more than 10% of our voting securities owned in the aggregate by FIMI and Bronicki;
|
|
|
§
|
allow, following January 1, 2017, the sale of our voting securities owned by FIMI and Bronicki only if they are not acting in concert to sell or, if they are, only with 20 days’ prior written notice to us, subject to certain exceptions for public sales and mergers and acquisitions transactions; and
|
|
|
§
|
prohibit FIMI and Bronicki from renewing their shareholder rights agreement beyond its expiration date, May 22, 2017.
|
|
|
o
|
a registration rights agreement whereby FIMI and Bronicki may, subject to certain limitations, require us to prepare and file with the SEC a registration statement to register a public offering of the shares of our common stock held by them, on customary terms and conditions set forth in the agreement.
|
|
·
|
voting and transfers of the shares of our common stock held by Bronicki Investments and FIMI following the share exchange (including a right of first offer, “tag-along” right, a “bring-along” right and, by way of an amendment to the SPA, a call option right to FIMI);
|
|
·
|
the composition of the board of directors of us and our active subsidiaries and the committees of our board of directors, as further detailed below;
|
|
·
|
agreements concerning various corporate policies and governance matters relating to us and our subsidiaries, to the extent subject to a vote of our stockholders (namely, that unless otherwise agreed and as long as the parties hold a certain minimum percentage of our share capital, the parties will vote against liquidation or entrance into any bankruptcy or similar proceeding by us (or a material subsidiary thereof, if under applicable law it is required to be brought to the parties’ approval), a material change in our field of operations (or a material subsidiary thereof, if under applicable law it is required to be brought to the parties’ approval), and/or amendment of our Articles of Association with respect to our staggered board of directors); and
|
|
·
|
compliance with the Israeli Tax Ruling, including the internal allocation between Bronicki Investments and FIMI of the amount of shares they are permitted to sell under the Israeli Tax Ruling.
|
|
·
|
subject to any applicable law and fiduciary duties, use their reasonable efforts to cause an equal number of designees of Bronicki Investments and FIMI ENRG to be elected or appointed to our board of directors and to the boards of all of our active subsidiaries and to the committees of our board of directors. Specifically, Bronicki Investments and FIMI ENRG agreed that they will each have the right to designate four members to our board of directors. The number of directors that Bronicki Investments and FIMI ENRG may designate is subject to staged adjustments if either Bronicki Investments or FIMI ENRG or both cease to own specified minimum numbers of our shares, within various ranges specified in the SHA; including minimum shareholdings below which such shareholder loses the right of directors’ designation; and
|
|
·
|
subject to any applicable law and subject to continued holding of certain minimum numbers of our shares, if our current CEO ceases to act as our CEO, use their best efforts to cause the nomination of Bronicki Investments’ designee as Chief Executive Officer or Chairman of our board or directors (as Bronicki Investments may decide in its sole discretion), and the appointment of FIMI's designee as the Chairman of our board of directors (if Bronicki Investments’ designee serves as Chief Executive Officer) or our Chief Executive Officer (if Bronicki Investments’ designee serves as Chairman of our board of directors).
|
|
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options, Warrants
and Rights
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights
|
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans
|
||||||||||
|
Equity Compensation plans approved
by security holders
|
4,477,405
*
|
$ | 27.15 | 2,163,900 | † | |||||||
|
Equity Compensation plans not approved by security holders
|
-- | N/A | -- | |||||||||
|
Total
|
4,477,405 | * | $ | 27.25 | 2,163,900 | † | ||||||
|
*
|
Stock options to be issued pursuant to our 2004 Incentive Compensation Plan, as amended, and our 2012 Incentive Compensation Plan, as amended, and our Registration Statement on Form S-8 covering 1,250,000 shares filed with the SEC on November 9, 2005, and our Registration Statement on Form S-8 covering 2,500,000 shares filed with the SEC on June 4, 2007, and our Registration Statement on Form S-8 covering 4,000,000 shares filed with the SEC on May 18, 2012.
|
|
†
|
On May 8, 2012, at the Company’s 2012 annual meeting of shareholders, the Company’s shareholders approved the Ormat Technologies, Inc. 2012 Incentive Compensation Plan, which the Board of Directors of the Company had adopted on March 20, 2012. No further awards will be granted under the 2004 Incentive Compensation Plan. On May 18, 2012, the Company filed a post-effective Amendment No. 1 to Form S-8 whereby the Company removed from registration 51,149 unissued shares that had remained available for grant under the 2004 Incentive Compensation Plan, as amended.
|
|
|
Year Ended December 31,
|
|
3-Year
Average
|
|||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
||||||||||
|
Options and SARs granted
|
|
485,000
|
1,303,100
|
687,250
|
|
|
||||||||||
|
Weighted average shares of common stock outstanding
|
|
45,859
|
45,475
|
45,431
|
|
|
||||||||||
|
Burn rate
|
|
1.06%
|
|
|
2.87%
|
|
|
1.51%
|
|
|
1.81
|
%
|
||||
|
2014
|
2013
|
|||||||
|
Audit Fees
(1)
|
$ | 2,075,600 | $ | 2,136,400 | ||||
|
Audit-Related Fees
(2)
|
$ | 16,200 | $ | 11,000 | ||||
|
Tax Fees
(3)
|
$ | 382,395 | $ | 164,900 | ||||
|
All Other Fees
(4)
|
$ | 36,100 | $ | 5,200 | ||||
|
Total
:
|
$ | 2,510,295 | $ | 2,317,500 | ||||
|
|
(1)
|
Audit Fees represent the aggregate fees billed for the audits of the annual financial statements and the Company’s internal control over financial reporting; for review of the financial statements included in the Company’s Form 10-Q filings; for the audits and reviews of certain of our subsidiaries; and for services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings.
|
|
|
(2)
|
Audit-Related Fees represent the aggregate fees billed for services related to the performance of the audit or review of our financial statements and are not reported under paragraph (1) above.
|
|
|
(3)
|
Tax Fees represent the aggregate fees billed for international tax compliance, tax advice, and tax planning services.
|
|
|
(4)
|
All Other Fees represent annual software license fees.
|
|
By order of the Board of Directors,
/s/ Isaac Angel
Isaac Angel
Chief Executive Officer
|
|
1.
|
Election of Directors.
|
| (1) Yehudit Bronicki |
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
| (2) Robert F. Clarke |
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
| (3) Ami Boehm |
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
|
2.
|
To ratify the selection of PricewaterhouseCoopers LLP as independent auditors of the Company for its fiscal year ending December 31, 2015.
|
|
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
|
3.
|
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting.
|
|
FOR
o
|
AGAINST
o
|
ABSTAIN
o
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|